Gordon Cann

Gordon Cann is an accomplished Principal Scientist at GRAIL, a position held since March 2016. Prior to joining GRAIL, Gordon Cann developed expertise as a Scientist II at Illumina from 2009 to March 2016. With extensive experience in genomic technologies and research, Gordon Cann contributes significantly to advancements in the field.